RxDoctor Payments Data

Adam Podet, MD

Neurological Surgery · New Orleans, LANPI 1255793113

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,624 of the $14,587 with a category attached, or 66.0%. It is spread thinly across 28 manufacturers, the largest accounting for just 20.2%. Reporting peaked in 2023 at $4,717 and has fallen 51.2% since, to $2,301 in 2025.

$14,587in general payments, 2019–2025

Across 148 payments — averaging $98.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zavation Medical Products, LLC$3K
  • Globus Medical$2K
  • Si-bone, Inc.$1K
  • Corelink, LLC$1K
  • Stryker$902
  • Spinal Elements, Inc.$640
  • plus $6K from 22 others

What the payments were for

  • Travel & lodging$4,96334%
  • Food & beverage$9,62466%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,587 in reported general payments places this provider in the 70th percentile of 116 neurological surgery providers in Louisiana.

See all neurological surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$60,178
Medicare patients
81
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$236
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$223
Gabapentin11$136

Paid to pharmacies, not to this prescriber.

Other neurological surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →